Patients / advocates

Colon Cancer Immunotherapy Moves Into the Adjuvant Access Test

Narcolepsy Treatment Starts Targeting the Cause

Optic Neuritis Moves Into the Neuroprotection Race

Infant Formula Botulism Turns Food Safety Into a Baby-Safety Emergency

Personalised cardiology cannot succeed if women’s hearts still follow men’s pathways

AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits

Cancer Is Chaos. Patients Should Not Have to Become Their Own Operating System

India’s emergency price-cap rise for cisplatin and carboplatin exposes a blunt oncology truth

Huntington’s Gene Therapy Moves Back Toward the FDA Door
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
